What are the predicting factors for the therapeutic effects of dutasteride in male patients with lower urinary tract symptoms? Investigation using a urodynamic study-Reference-Cited by-同舟云学术

What are the predicting factors for the therapeutic effects of dutasteride in male patients with lower urinary tract symptoms? Investigation using a urodynamic study

Published:2017-01-19 Issue:7 Volume:36 Page:1809-1815
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Matsukawa Yoshihisa¹,Kato Masashi¹,Funahashi Yasuhito¹,Majima Tsuyoshi¹,Yamamoto Tokunori¹,Gotoh Momokazu¹

Affiliation:

1. Department of Urology; Nagoya University Graduate School of Medicine; Nagoya Japan

Publisher

Wiley

Subject

Urology,Clinical Neurology

Reference24 articles.

1. Outline of JUA clinical guidelines for benign prostatic hyperplasia;Homma;Int J Urol,2011

2. EAU Guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms, incl. benign prostatic obstruction (BPO);Oelke;Eur Urol,2013

3. Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia;Tsukamoto;Int J Urol,2009

4. Effects of dutasteride on storage and voiding symptoms in male patients with lower urinary tract symptoms as a result of benign prostatic obstruction: the 1-year outcomes from a prospective urodynamic study;Matsukawa;Int J Urol,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Diagnostic Maze: Unraveling the Non-invasive Evaluation of Bladder Outlet Obstruction in Men—a Comprehensive Systematic Review;Current Bladder Dysfunction Reports;2023-10-28

2. Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement;International Urology and Nephrology;2021-11-12

3. Clinical characteristics and useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non‐neurogenic lower urinary tract symptoms;International Journal of Urology;2019-09-21

4. Symptom improvement and predictors associated with improvement after 6 weeks of alpha-blocker therapy: An exploratory, single-arm, open-label cohort study;PLOS ONE;2019-07-25

5. Pre-treatment serum testosterone level can be a useful factor to predict the improvement in bladder outlet obstruction by tadalafil for male patients with lower urinary tract symptoms induced by benign prostatic obstruction;The Aging Male;2019-01-16